Evidence map›Paper›PMID 33040272›Full record

ArticleInternal and emergency medicine2021

Clinical characteristics and outcomes in elderly with coronavirus disease 2019 in Beijing, China: a retrospective cohort study.

Wei Zhang, Wei Hou, Ronghua Jin, Lianchun Liang, Bin Xu, Zhongjie Hu

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal and emergency medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Wei ZhangDepartment of Critical Care Medicine of Liver Disease, Beijing YouAn Hospital, Capital Medical University, No. 8 YouAn Men Wai Street, Beijing, 100069, Fengtai, China.
Wei HouDepartment of Critical Care Medicine of Liver Disease, Beijing YouAn Hospital, Capital Medical University, No. 8 YouAn Men Wai Street, Beijing, 100069, Fengtai, China.
Ronghua JinDepartment of Critical Care Medicine of Liver Disease, Beijing YouAn Hospital, Capital Medical University, No. 8 YouAn Men Wai Street, Beijing, 100069, Fengtai, China.
Lianchun LiangDepartment of Critical Care Medicine of Liver Disease, Beijing YouAn Hospital, Capital Medical University, No. 8 YouAn Men Wai Street, Beijing, 100069, Fengtai, China.
Bin XuDepartment of Critical Care Medicine of Liver Disease, Beijing YouAn Hospital, Capital Medical University, No. 8 YouAn Men Wai Street, Beijing, 100069, Fengtai, China.
Zhongjie HuDepartment of Critical Care Medicine of Liver Disease, Beijing YouAn Hospital, Capital Medical University, No. 8 YouAn Men Wai Street, Beijing, 100069, Fengtai, China. dr_huzhongjie@163.com.ORCID http://orcid.org/0000-0001-7313-5326
Capital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel human coronavirus, known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a global pandemic of coronavirus disease 2019 (COVID-19). In this study, we aimed to explore the clinical characteristics and outcomes in older patients with COVID-19. Ninety-one patients with SARS-CoV-2 infection were included in the study, 27 of which (29.67%) were elderly. The median age of these 27 patients was 74.9 years (interquartile range 68-82; range 65-94 years), and 15 (55.56%) were female. Elderly with COVID-19 in Beijing (China) were more likely to have underlying comorbidities and more frequently tended to have critical illness and suffer from more complications. The main treatments of the elderly consisted of symptomatic and respiratory support. The most frequent complications in the elderly were pleural effusion [10, (37.04%)], secondary infection [7, (25.93%)], and kidney damage [7, (25.93%)]. Six (22.22%) of the 27 elderly patients received invasive ventilation (three of them switched to extracorporeal membrane oxygenation). As of March 7, 20 (74.07%) of the 27 elderly patients were discharged, two (7.41%) were still hospitalized, and five died; the mortality in the elderly was 18.52%. Age was associated with the mortality in patients with COVID-19 (OR 0.82; 95% CI 0.70-0.97; P = 0.019). Therefore, more attention should be paid to the treatment of comorbidities and complications in elderly patients.

Indexed as

AgedAged, 80 and overAge FactorsChinaCOVID-19Critical CareFemaleHospitalizationHumansMaleMiddle AgedRetrospective StudiesSurvival Rate2019 novel coronavirus disease (COVID-19)Clinical characteristicsElderlyOutcome

Identifiers

PMID33040272
PMCPMC7547816
OpenAlexW3092631009

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.